BRPW
ABBV icon

Ballast Rock Private Wealth’s AbbVie ABBV Stock Holding History

Ballast Rock Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
1,308
+8
+0.6% +$1.72K 0.15% 138
2026
Q1 		$283K Sell
1,300
-3
-0.2% -$665 0.16% 153
2025
Q4 		$298K Buy
+1,303
New +$297K 0.19% 137

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ballast Rock Private Wealth's ABBV Position: Q2 2026 in Review

Ballast Rock Private Wealth increased its AbbVie (ABBV) stake by 0.62% in Q2 2026, buying an estimated $1.72K and bringing the position to 1,308 shares worth $329K. The position accounts for 0.15% of the portfolio, ranked #138.

Ballast Rock Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ballast Rock Private Wealth held 1,308 shares of AbbVie worth $329K as of Q2 2026.
  • Ballast Rock Private Wealth bought 8 AbbVie shares in Q2 2026, an estimated $1.72K.
  • AbbVie made up 0.15% of Ballast Rock Private Wealth's portfolio in Q2 2026, its #138 holding.
  • Ballast Rock Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ballast Rock Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.